Elizabeth A Rohan1, Nina Miller2, Floyd Bonner3, Kristi Fultz-Butts3, Mandi L Pratt-Chapman4, Catherine M Alfano5, Kristen Cox Santiago6, Kendall Bergman7, Eric Tai3. 1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F76, Chamblee, Atlanta, GA, 30341-3717, USA. erohan@cdc.gov. 2. American College of Surgeons, Commission on Cancer, Cancer Liaison Initiatives, Chicago, IL, USA. 3. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F76, Chamblee, Atlanta, GA, 30341-3717, USA. 4. George Washington University Cancer Center, Patient-Centered Initiatives & Health Equity, Washington, DC, USA. 5. American Cancer Society, Inc, Atlanta, GA, USA. 6. Cancer Support Community, Washington, DC, USA. 7. LIVESTRONG, Austin, TX, USA.
Abstract
PURPOSE: As of 2016, an estimated 15.5 million cancer survivors were living in the United States and the number of cancer survivors is expected to increase to 20.3 million by 2026. Numerous clinical studies have shown that comorbidities, such as obesity and diabetes, and unhealthy lifestyle choices, such as physical inactivity and heavy smoking, negatively influence overall quality of life and long-term survival of cancer survivors. Accordingly, survivorship programs seek to focus on overall wellness, including symptom management, monitoring for late effects of treatment, monitoring for recurrence, helping patients adapt healthy behaviors, and quality of life. This paper provides a broad overview of public health efforts to address the needs of cancer survivors. METHODS: To describe a range of examples of survivorship initiatives in comprehensive cancer control, we analyzed documents from comprehensive cancer control programs and coalitions and solicited detailed examples from several national partners. RESULTS: Comprehensive cancer control programs, coalitions, and partners are undertaking myriad initiatives to address cancer survivorship and building upon evidence-based interventions to promote healthy behaviors for cancer survivors across the country. CONCLUSION: A coordinated public health approach to caring for the growing population of cancer survivors can help address the long-term physical, psychosocial, and economic effects of cancer treatment on cancer survivors and their families.
PURPOSE: As of 2016, an estimated 15.5 million cancer survivors were living in the United States and the number of cancer survivors is expected to increase to 20.3 million by 2026. Numerous clinical studies have shown that comorbidities, such as obesity and diabetes, and unhealthy lifestyle choices, such as physical inactivity and heavy smoking, negatively influence overall quality of life and long-term survival of cancer survivors. Accordingly, survivorship programs seek to focus on overall wellness, including symptom management, monitoring for late effects of treatment, monitoring for recurrence, helping patients adapt healthy behaviors, and quality of life. This paper provides a broad overview of public health efforts to address the needs of cancer survivors. METHODS: To describe a range of examples of survivorship initiatives in comprehensive cancer control, we analyzed documents from comprehensive cancer control programs and coalitions and solicited detailed examples from several national partners. RESULTS: Comprehensive cancer control programs, coalitions, and partners are undertaking myriad initiatives to address cancer survivorship and building upon evidence-based interventions to promote healthy behaviors for cancer survivors across the country. CONCLUSION: A coordinated public health approach to caring for the growing population of cancer survivors can help address the long-term physical, psychosocial, and economic effects of cancer treatment on cancer survivors and their families.
Entities:
Keywords:
Cancer survivorship; Comprehensive cancer control; Health promotion; Public health
Authors: Jeffrey A Lafranca; Sander M Hagen; Leonienke F C Dols; Lidia R Arends; Willem Weimar; Jan N M Ijzermans; Frank J M F Dor Journal: Kidney Int Date: 2013-01-23 Impact factor: 10.612
Authors: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charles S Fuchs Journal: J Clin Oncol Date: 2006-07-05 Impact factor: 44.544
Authors: Jeanne Carter; Christina Lacchetti; Barbara L Andersen; Debra L Barton; Sage Bolte; Shari Damast; Michael A Diefenbach; Katherine DuHamel; Judith Florendo; Patricia A Ganz; Shari Goldfarb; Sigrun Hallmeyer; David M Kushner; Julia H Rowland Journal: J Clin Oncol Date: 2017-12-11 Impact factor: 44.544
Authors: Balazs I Bodai; Therese E Nakata; William T Wong; Dawn R Clark; Steven Lawenda; Christine Tsou; Raymond Liu; Linda Shiue; Neil Cooper; Michael Rehbein; Benjamin P Ha; Anne Mckeirnan; Rajiv Misquitta; Pankaj Vij; Andrew Klonecke; Carmelo S Mejia; Emil Dionysian; Sean Hashmi; Michael Greger; Scott Stoll; Thomas M Campbell Journal: Perm J Date: 2018
Authors: Leslie S Given; Karin Hohman; Lorrie Graaf; Phyllis Rochester; Lori Belle-Isle Journal: Cancer Causes Control Date: 2010-10-12 Impact factor: 2.506
Authors: Maria Kyrgiou; Ilkka Kalliala; Georgios Markozannes; Marc J Gunter; Evangelos Paraskevaidis; Hani Gabra; Pierre Martin-Hirsch; Konstantinos K Tsilidis Journal: BMJ Date: 2017-02-28
Authors: Michelle A Mollica; Angela L Falisi; Ann M Geiger; Paul B Jacobsen; Natasha Buchanan Lunsford; Mandi L Pratt-Chapman; Julie S Townsend; Larissa Nekhlyudov Journal: J Cancer Surviv Date: 2020-01-17 Impact factor: 4.442
Authors: Luigino Dal Maso; Chiara Panato; Stefano Guzzinati; Diego Serraino; Silvia Francisci; Laura Botta; Riccardo Capocaccia; Andrea Tavilla; Anna Gigli; Emanuele Crocetti; Massimo Rugge; Giovanna Tagliabue; Rosa Angela Filiberti; Giuliano Carrozzi; Maria Michiara; Stefano Ferretti; Rosaria Cesaraccio; Rosario Tumino; Fabio Falcini; Fabrizio Stracci; Antonietta Torrisi; Guido Mazzoleni; Mario Fusco; Stefano Rosso; Francesco Tisano; Anna Clara Fanetti; Giovanna Maria Sini; Carlotta Buzzoni; Roberta De Angelis Journal: Cancer Med Date: 2019-06-17 Impact factor: 4.452